Sirius Workforce Development Revenue and Competitors
Estimated Revenue & Valuation
- Sirius Workforce Development's estimated annual revenue is currently $100.5k per year.
- Sirius Workforce Development's estimated revenue per employee is $100,500
Employee Data
- Sirius Workforce Development has 1 Employees.
- Sirius Workforce Development grew their employee count by -50% last year.
Sirius Workforce Development's People
Name | Title | Email/Phone |
---|---|---|
1 | Director Workforce Development | Reveal Email/Phone |
Sirius Workforce Development Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $26.1M | 130 | -1% | N/A | N/A |
#2 | $3.8M | 27 | 4% | N/A | N/A |
#3 | $23.1M | 115 | -4% | N/A | N/A |
#4 | $75.9M | 302 | 7% | N/A | N/A |
#5 | $6.9M | 43 | 5% | N/A | N/A |
#6 | $43.8M | 198 | N/A | N/A | N/A |
#7 | $38.3M | 173 | 7% | N/A | N/A |
#8 | $24.1M | 120 | 20% | N/A | N/A |
#9 | $0.1M | 1 | -50% | N/A | N/A |
#10 | $7.4M | 46 | 2200% | N/A | N/A |
What Is Sirius Workforce Development?
Sirius Workforce Development is committed to strengthening the US labor market through the support of federal, state, local, and corporate programs targeted at job creation (training, development, and placement). Sirius brings proven, scalable, and robust back-office functions (HR, payroll, benefits) which compliment the mission focused work of our clients and partners. We are devoted to bolstering the efficiency and effectiveness of organizations who support underserved communities.
keywords:N/AN/A
Total Funding
1
Number of Employees
$100.5k
Revenue (est)
-50%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Sirius Workforce Development News
Netherlands-based ProQR Therapeutics, which is developing RNA ... a readout of the Phase II/III Sirius clinical trial of ultevursen,...
has decided to prioritize the development of genetic eye disease ... and retinitis pigmentosa on a single Phase 2/3 Sirius trial with the...
Genetic eye diseases Explore development path for selected ophthalmology ... readout of the modified Phase 2/3 Sirius trial of ultevursen.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.3M | 2 | -94% | N/A |
#2 | $0.6M | 5 | 25% | N/A |
#3 | $0.5M | 7 | 0% | N/A |
#4 | $4.1M | 20 | -50% | N/A |
#5 | $4.3M | 23 | 0% | N/A |